The ambiguity of brain metastasis response to radiotherapy driven by cellular adhesion molecules
Brain metastases treatments are usually based on surgery and radiation therapies with poor patient survival. Cellular adhesion molecules (CAMs) are promiscuous proteins highly involved in tumour progression. Owing to their dual functionality in structure and signalling, CAMs have emerged as potentia...
| Үндсэн зохиолчид: | , , , , |
|---|---|
| Формат: | Conference item |
| Хэвлэсэн: |
Oxford University Press
2017
|
| _version_ | 1826256780845383680 |
|---|---|
| author | Soto, M Larkin, J Andreou, K Simoglou, C Sibson, N |
| author_facet | Soto, M Larkin, J Andreou, K Simoglou, C Sibson, N |
| author_sort | Soto, M |
| collection | OXFORD |
| description | Brain metastases treatments are usually based on surgery and radiation therapies with poor patient survival. Cellular adhesion molecules (CAMs) are promiscuous proteins highly involved in tumour progression. Owing to their dual functionality in structure and signalling, CAMs have emerged as potential targets in the clinic. It has been shown that CAMs can modulate radiation response in different types of tumours, triggering either apoptosis or resistance. However, this complex behaviour has not been studied in brain metastasis. In recent years, we have demonstrated a role of several CAMs during brain metastasis progression. For example, disrupting interactions between circulating tumour cells and brain vasculature using antibodies against ALCAM (CD166) and VLA-4 (α4β1), resulted in a significant decrease in metastatic colonies. Similarly, after LFA-1 (αLβ2) knockdown in tumour cells, brain metastasis growth was greatly reduced. On this basis, the aim of the current study was to determine the effect of concomitant stereotactic brain radiotherapy (SARRP) and anti-CAM treatments in breast cancer brain metastasis in vivo models. |
| first_indexed | 2024-03-06T18:07:41Z |
| format | Conference item |
| id | oxford-uuid:01f9b7d0-a5db-4023-ba24-25c5e922dcb6 |
| institution | University of Oxford |
| last_indexed | 2024-03-06T18:07:41Z |
| publishDate | 2017 |
| publisher | Oxford University Press |
| record_format | dspace |
| spelling | oxford-uuid:01f9b7d0-a5db-4023-ba24-25c5e922dcb62022-03-26T08:38:02ZThe ambiguity of brain metastasis response to radiotherapy driven by cellular adhesion moleculesConference itemhttp://purl.org/coar/resource_type/c_5794uuid:01f9b7d0-a5db-4023-ba24-25c5e922dcb6Symplectic Elements at OxfordOxford University Press2017Soto, MLarkin, JAndreou, KSimoglou, CSibson, NBrain metastases treatments are usually based on surgery and radiation therapies with poor patient survival. Cellular adhesion molecules (CAMs) are promiscuous proteins highly involved in tumour progression. Owing to their dual functionality in structure and signalling, CAMs have emerged as potential targets in the clinic. It has been shown that CAMs can modulate radiation response in different types of tumours, triggering either apoptosis or resistance. However, this complex behaviour has not been studied in brain metastasis. In recent years, we have demonstrated a role of several CAMs during brain metastasis progression. For example, disrupting interactions between circulating tumour cells and brain vasculature using antibodies against ALCAM (CD166) and VLA-4 (α4β1), resulted in a significant decrease in metastatic colonies. Similarly, after LFA-1 (αLβ2) knockdown in tumour cells, brain metastasis growth was greatly reduced. On this basis, the aim of the current study was to determine the effect of concomitant stereotactic brain radiotherapy (SARRP) and anti-CAM treatments in breast cancer brain metastasis in vivo models. |
| spellingShingle | Soto, M Larkin, J Andreou, K Simoglou, C Sibson, N The ambiguity of brain metastasis response to radiotherapy driven by cellular adhesion molecules |
| title | The ambiguity of brain metastasis response to radiotherapy driven by cellular adhesion molecules |
| title_full | The ambiguity of brain metastasis response to radiotherapy driven by cellular adhesion molecules |
| title_fullStr | The ambiguity of brain metastasis response to radiotherapy driven by cellular adhesion molecules |
| title_full_unstemmed | The ambiguity of brain metastasis response to radiotherapy driven by cellular adhesion molecules |
| title_short | The ambiguity of brain metastasis response to radiotherapy driven by cellular adhesion molecules |
| title_sort | ambiguity of brain metastasis response to radiotherapy driven by cellular adhesion molecules |
| work_keys_str_mv | AT sotom theambiguityofbrainmetastasisresponsetoradiotherapydrivenbycellularadhesionmolecules AT larkinj theambiguityofbrainmetastasisresponsetoradiotherapydrivenbycellularadhesionmolecules AT andreouk theambiguityofbrainmetastasisresponsetoradiotherapydrivenbycellularadhesionmolecules AT simoglouc theambiguityofbrainmetastasisresponsetoradiotherapydrivenbycellularadhesionmolecules AT sibsonn theambiguityofbrainmetastasisresponsetoradiotherapydrivenbycellularadhesionmolecules AT sotom ambiguityofbrainmetastasisresponsetoradiotherapydrivenbycellularadhesionmolecules AT larkinj ambiguityofbrainmetastasisresponsetoradiotherapydrivenbycellularadhesionmolecules AT andreouk ambiguityofbrainmetastasisresponsetoradiotherapydrivenbycellularadhesionmolecules AT simoglouc ambiguityofbrainmetastasisresponsetoradiotherapydrivenbycellularadhesionmolecules AT sibsonn ambiguityofbrainmetastasisresponsetoradiotherapydrivenbycellularadhesionmolecules |